EPISODE · Jul 25, 2023 · 16 MIN
BLIMPITIS: USA WE RE #1
from Gerald Celente - Trends in the News · host Gerald Celente
Your New Trends Journal is out "BLIMPITIS: USA WE'RE #1" In today's episode Gerald Celente describes the new virus plaguing the world, blimpitis. Also, the latest updates in the Middle East, Ukraine and the economic outlook. The Trends Journal is a weekly magazine analyzing global current events forming future trends. Our mission is to present Facts and Truth over fear and propaganda to help subscribers prepare for What’s Next in these increasingly turbulent times. To access our premium content, subscribe to the Trends Journal: https://trendsresearch.com/subscribe Follow Gerald Celente on Twitter: http://twitter.com/geraldcelente Follow Gerald Celente on Facebook: http://facebook.com/gcelente Follow Gerald Celente on Instagram: https://www.instagram.com/geraldcelen... Follow Gerald Celente on Gab: http://gab.com/geraldcelente Copyright © 2023 Trends Research Institute. All rights reserved.
What this episode covers
Your New Trends Journal is out "BLIMPITIS: USA WE'RE #1" In today's episode Gerald Celente describes the new virus plaguing the world, blimpitis. Also, the latest updates in the Middle East, Ukraine and the economic outlook. The Trends Journal is a weekly magazine analyzing global current events forming future trends. Our mission is to present Facts and Truth over fear and propaganda to help subscribers prepare for What’s Next in these increasingly turbulent times. To access our premium content, subscribe to the Trends Journal: https://trendsresearch.com/subscribe Follow Gerald Celente on Twitter: http://twitter.com/geraldcelente Follow Gerald Celente on Facebook: http://facebook.com/gcelente Follow Gerald Celente on Instagram: https://www.instagram.com/geraldcelen... Follow Gerald Celente on Gab: http://gab.com/geraldcelente Copyright © 2023 Trends Research Institute. All rights reserved.
NOW PLAYING
BLIMPITIS: USA WE RE #1
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m